<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2015-02-16</publicationDate>
    
        <volume>2</volume>
        <issue>2</issue>

 
    <startPage>363</startPage>
    <endPage>368</endPage>

	    <publisherRecordId>860</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Oxidative Stress in Secondary Nephrotic Syndrome: Recent Advances with Homocysteine, Copper and Zinc</title>

    <authors>
	 


      <author>
       <name>Jyoti Dwivedi</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Purnima Dey Sarkar</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Biochemistry, S.S. Medical College Rewa - 486 001 (India). </affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Biochemistry, N.S.C.B. Medical College Jabalpur - 482 003 (India).</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Imbalance in oxidant/antioxidant status is well document in patients with nephrotic syndrome &amp; secondary nephrotic syndrome. Serum total antioxidant capacity, malondialdehyde, homocysteine, copper, zinc, plasma vitamin C were estimated in 2 groups, group I comprised of 50 nephrotic syndrome patients and group II comprised of 41 secondary nephrotic syndrome patients. It was observed there were decreased level of serum total antioxidant capacity (P&lt;0.0001), copper (P&lt;0.02), zinc (P&lt;0.02), plasma vitamin C (P&lt;0.0001) and increased serum level of malondialdehyde, homocysteine (P&lt;0.0001) in secondary nephrotic group II when compared to nephrotic group I. Serum homocysteine were significantly positive correlated with MDA, negative correlated with serum Cu &amp; Zn in nephrotic group. In conclusion increased oxidative stress in secondary nephrotic syndrome than nephrotic syndrome. Hyperhomocyst(e)inemia is related to decrease concentration of copper, zinc and supported to oxidative stress &amp; endothelial dysfunction in nephrotic syndrome and secondary nephrotic syndrome.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol2no2/oxidative-stress-in-secondary-nephrotic-syndrome-recent-advances-with-homocysteine-copper-and-zinc/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Nephrotic Syndrome</keyword>
      

      
        <keyword> Total antioxidant capacity</keyword>
      

      
        <keyword> Homocysteine</keyword>
      

      
        <keyword> Malondialdehyde</keyword>
      
</keywords>
  </record>
</records>